Table 2 Subgroup analysis of continents and countries based on molecular methods in dogs
Continents/countries | Datasets (n) | Sample size (n) | Infected (n) | Pooled prevalence % (95% CI) |
|---|---|---|---|---|
Global | 23 | 3971 | 329 | 8.4 (6.1–11.5) |
Asia | 11 | 2515 | 195 | 7.7 (4.6–12.5) |
 China | 5 | 1441 | 130 | 8.6 (5.5–13.4) |
 Iran | 3 | 192 | 37 | 13.7 (3.5–40.9) |
 Japan | 2 | 676 | 28 | 4.2 (2.9–6) |
 Thailand | 1 | 206 | 0 | 0 |
Europe | 9 | 886 | 78 | 8.2 (5–13.2) |
 Spain | 3 | 327 | 18 | 6.4 (0.9–33.5) |
 Portugal | 2 | 94 | 6 | 6.6 (3–13.8) |
 Poland | 2 | 147 | 10 | 6.8 (3.7–12.2) |
 Switzerland | 1 | 36 | 3 | 8.3 (2.7–22.9) |
 Turkey | 1 | 282 | 41 | 14.5 (10.9–19.2) |
America | 1 | 120 | 18 | 15 (9.7–22.6) |
 Colombia | 1 | 120 | 18 | 15 (9.7–22.6) |
Africa | 1 | 108 | 23 | 21.3 (14.6–30) |
 Egypt | 1 | 108 | 23 | 21.3 (14.6–30) |
Oceania | 1 | 342 | 15 | 4.4 (2.7–7.1) |
 Australia | 1 | 342 | 15 | 4.4 (2.7–7.1) |